Please join us in Geneva for three exciting days of presentations by invited speakers as well as late-breaking oral presentations and posters.

The bi-annual International Geneva/Springfield Symposium on Advances in Alzheimer Therapy distinguishes itself from other scientific meetings of this kind for two main characteristics.

First, is the only international meeting that focuses entirely on the pharmacological therapy of Alzheimer Disease with particular emphasis on the discovery of new drugs. The theme includes: drug development at different preclinical and clinical stages, results of clinical trials and pharmaco-economics implications.

Second, the meeting is organized jointly by an American (Southern Illinois University, School of Medicine in Springfield Illinois, USA) and a European (University of Geneva, Medical School Dept. of Rehabilitation and Geriatrics) University.

Our next meeting which is planned to take place in Geneva, March 24-27, 2010, will be the 11th of the series. The last one was in Hong Kong in 2008 with 1200 participants.

We expect that the results of several new clinical trials, presently in progress in the whole world, will be communicated at the 2010 meeting. The meeting is also unique insofar as bringing together basic and clinical experts of this area from academia as well as from the most important pharmaceutical companies. We would like to underline the fact that several drugs presently used in the treatment of Alzheimer Disease were first presented at various Springfield meetings .The Springfield meeting which spans over 3 days, includes monothematic Symposia, communications on New Therapies and posters.

The conference will be useful to specialists, mainly neurologists, psychiatrists and geriatricians as well to any one caring for Alzheimer patients, in order to understand the pharmacological approach to the disease.

Links on this page that are followed by (pdf) are Adobe Acrobat files and require that the free reader be installed on your computer. The reader is available for download on the Adobe website.